Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: Relation to inflammation, glycemic control and micro-vascular complications

El Samahy, Mona H; Adly, Amira A.M.; Ismail, Eman A.; Salah, Nouran;

Abstract


Background Alteration of regulatory T cells (Tregs) may contribute to ineffective suppression of proinflammatory cytokines in type 1 diabetes. Aim We determined the percentage of Tregs expressing CD62L or tumor necrosis factor receptor type 2 (TNFR2) in 70 young type 1 diabetic patients compared with 30 controls and assessed their relation to inflammation, glycemic control and micro-vascular complications.


Other data

Title Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: Relation to inflammation, glycemic control and micro-vascular complications
Authors El Samahy, Mona H ; Adly, Amira A.M.; Ismail, Eman A.; Salah, Nouran 
Keywords CD62L;Micro-vascular complications;TNFR2;Tregs;Type 1 diabetes
Issue Date 1-Jan-2015
Journal Journal of Diabetes and its Complications 
Volume 29
Issue 1
Start page 120
End page 126
ISSN 10568727
DOI 10.1016/j.jdiacomp.2014.07.004
PubMed ID 25113439
Scopus ID 2-s2.0-84920516509

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 6 in pubmed
Citations 8 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.